Evidence map›Paper›PMID 33922377›Full record

ArticleInternational journal of molecular sciences2021

Effects of Haloperidol, Risperidone, and Aripiprazole on the Immunometabolic Properties of BV-2 Microglial Cells.

Valentino Racki, Marina Marcelic, Igor Stimac, Daniela Petric, Natalia Kucic

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Valentino RackiDepartment of Neurology, Medical Faculty, University of Rijeka, 51000 Rijeka, Croatia.ORCID 0000-0003-3246-0506
Marina MarcelicDepartment of Physiology and Immunology, Medical Faculty, University of Rijeka, 51000 Rijeka, Croatia.
Igor StimacDepartment of Physiology and Immunology, Medical Faculty, University of Rijeka, 51000 Rijeka, Croatia.ORCID 0000-0001-6696-5903
Daniela PetricDepartment of Psychiatry, Medical Faculty, University of Rijeka, 51000 Rijeka, Croatia.
Natalia KucicDepartment of Physiology and Immunology, Medical Faculty, University of Rijeka, 51000 Rijeka, Croatia.ORCID 0000-0003-1486-4208

Funding

University of Rijeka No. 13.06.1.3.45.
6 · The paper itself

Abstract

Microglial cells are resident macrophages in the brain that have been implicated in the pathophysiology of schizophrenia. There is a lack of studies covering the effects of antipsychotics on microglial cells. The current literature points to a possible anti-inflammatory action without clear mechanisms of action. The aim of this study is to characterize the effects of haloperidol, risperidone and aripiprazole on BV-2 microglial cells in in vitro conditions. We have used immunofluorescence and flow cytometry to analyze the classical pro and anti-inflammatory markers, while a real-time metabolic assay (Seahorse) was used to assess metabolic function. We analyzed the expression of p70S6K to evaluate the mTOR pathway activity with Western blot. In this study, we demonstrate the varying effects of haloperidol, risperidone and aripiprazole administration in BV-2 microglial cells. All three tested antipsychotics were successful in reducing the pro-inflammatory action of microglial cells, although only aripiprazole increased the expression of anti-inflammatory markers. Most significant differences in the possible mechanisms of action were seen in the real-time metabolic assays and in the mTORC1 signaling pathway activity, with aripiprazole being the only antipsychotic to reduce the mTORC1 activity. Our results shed some new light on the effects of haloperidol, risperidone and aripiprazole action in microglial cells, and reveal a novel possible mechanism of action for aripiprazole.

Indexed as

Antipsychotic AgentsAripiprazoleCells, CulturedCell SurvivalHaloperidolHumansInflammation MediatorsMicrogliaRisperidoneAntipsychotic AgentsAripiprazoleHaloperidolInflammation MediatorsRisperidoneantipsychoticsaripiprazolehaloperidolimmunometabolismmicrogliarisperidone

Identifiers

PMID33922377
PMCPMC8122792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.